This is by no means a stock to be short in or flip. Once BMSN get's approvals, It'll retain it's PPS, but in general, FDA related stuff takes a long time. Hema clinical trials will be much quicker though, once it received FDA Orphan designation.
Biotech's in general, take a long time to get off the ground, fortunately BMSN is at it's golden moment, like no other moment in it's past. Right now is a ground breaking moment for BMSN, and in the coming weeks, we'll all see why.
The opinions, comments, or concerns, expressed herein, are solely that of 'd5wr59mfi8'; They're not to be misconstrued as any form of advice, and any suggestions should not be followed.